Search the Newsroom
Filter By
Showing 2491 - 2500 of 2709 results
Two Companies Receive Seed Grants to Develop Medical Devices for Children
A local CHOP-based consortium announces grants to develop pediatric medical tools — one to reduce pain in a medical procedure, another to reduce antibiotic overuse.
Case Study - Hydrocephalus Pathway
A case study of a patient with intraventricular hemorrhage who underwent a reservoir placement in the N/IICU at CHOP. In the subsequent days, the reservoir was tapped for tense fontanelle and rapid head growth.
Make the Diagnosis: Winter 2016
A 17-year-old previously healthy Caucasian female presents with recent history of syncope while rowing in open water. She fainted and fell out of her boat while rowing with her crew team.
Alumni Notes Winter 2016
Alumni notes from Winter 2016.
New Drug May Overcome Treatment Resistance in a High-risk Children’s Cancer
CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.
Historic Double Hand Transplant
Zion Harvey received a double hand transplant at The Children's Hospital of Philadelphia — first child to undergo this procedure. Zion received OT and PT several times a day during his recovery.
Pediatric Neuro-ophthalmologist Robert A. Avery, DO, MSCE, Joins Division of Ophthalmology
The Children's Hospital of Philadelphia’s Division of Pediatric Ophthalmology welcomes neuro-ophthalmologist Robert A. Avery, DO, MSCE.
The Children’s Hospital of Philadelphia Participates in Spark Therapeutics Public Offering
Spark Therapeutics, Inc. recently announced a public offering issuing two-million primary shares at $47.00 per share. Included in the sale as a secondary offering are one-million shares, at $47.00, held by CHOP.
Gaps in Care for Child Trauma and Stress after Injury
An international survey finds gap in knowledge when dealing with child traumatic stress.
The Children’s Hospital of Philadelphia Chooses New Chief Operating Officer
The Children’s Hospital of Philadelphia has chosen Douglas G. Hock as its new executive vice president and chief operating officer, beginning on Feb. 1.